The FDA approves AstraZeneca's sBLA for Enhertu to treat HER2-low or HER2-ultralow metastatic breast cancer in the United ...

Samsung Bioepis' Q1 2025 report shows oncology, ophthalmology, and pegfilgrastim biosimilars have gained significant market share, while immunology, filgrastim, epoetin alfa, and insulin glargine ...

CHENGDU, China I January 07, 2025 I The board (the “Board”) of directors (“Directors”) of Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the “Company”) is ...

LOS ANGELES - The FDA unveiled a proposal Tuesday to require front-of-package nutrition labels on most packaged foods, a major step in combating chronic diseases. The labels, called "Nutrition ...

An updated long-term analysis of the Phase III KATHERINE trial confirms that adjuvant treatment with Kadcyla (trastuzumab ...

Trastuzumab emtansine (T-DM1) demonstrates sustained improvement in invasive disease-free survival and reduced the risk for death in human epidermal growth factor receptor 2 (HER2)-positive breast ...

The primary analysis of KATHERINE, a phase 3, open-label trial, showed that the risk of invasive breast cancer or death was 50% lower with adjuvant trastuzumab emtansine (T-DM1) than with ...

The FDA's rule proposal would, if finalized, require U.S. food manufacturers to add a front-of-package (FOP) nutrition label on most packaged food goods produced in the United States. Related ...

MANILA, Philippines — The move of the Department of Agriculture (DA) to remove brand labels and premium classifications on imported rice is a “shallow attempt” at addressing price ...

Anyone can access those results by scanning a QR code on the baby food label with their smartphones. The new law applies only to sales of baby food in California, but major manufacturers ...